ENG
Monkey pox Vaccine and Treatment Market Industry Overview, Size, Share, Growth Trends, Research Insights and Forecast (2025–2032)
Monkeypox Vaccine and Treatment Market size was valued at USD 103.5 Mn in 2024 and the total Global Monkeypox Vaccine and Treatment revenue is expected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.
Format : PDF | Report ID : SMR_2670
Monkeypox Vaccine and Treatment Market Overview
The monkeypox vaccine is a vaccine designed to prevent monkeypox, a viral infection caused by the monkeypox virus. The treatment for monkeypox includes the over-the-counter medications, (acetaminophen, ibuprofen, etc), antiviral medications like Tecovirimat, cidofovir and brincidofovir (in certain situations) and antihistamines to alleviate itching caused by rashes.
The market for monkeypox vaccine and treatment is expected to expand owing to the growth of R&D being conducted and the awareness of people about monkeypox with the help of government initiatives. In addition, the U.S. government and its international partners are stepping up monkeypox research support. Research efforts for infection, funded by the government include clinical and epidemiologic observational modelling, vaccine and therapeutic clinical trial activities. In the next few such strategies will drive the uptake of vaccination to an exponentially rising level.
In Sept 2024, Bavarian Nordic signed an agreement with UNICEF to provide two doses of monkeypox vaccine (collectively with JYNNEOS) to various African nations affected by the monkeypox outbreak, with all doses set to delivered in 2025. Monkeypox outbreak in the Africa region, mainly in the Democratic Republic of Congo, leading Gavi, the global vaccine alliance buys 500,000 doses of monkeypox vaccine (JYNNEOS). JYNNEOS has been given the green light for use among adolescents aged 12 to 17 by the European Medicines Agency's CHMP, bolstering the fight against the monkeypox outbreak in Africa. Bavarian Nordic to raise its monkeypox vaccine production capacity to support delivery of up to 13 million monkeypox vaccine doses at the end of 2025.
To get more Insights: Request Free Sample Report
Monkeypox Vaccine and Treatment Market Dynamics
Rising Concerns about Monkeypox Outbreaks to Boost the Monkeypox Vaccine and Treatment Market
The speedy transmissibility of monkeypox has made the arena take note of worldwide health protection, that is one of the drivers for the monkeypox vaccine and treatment market. The outbreaks of monkeypox in non-endemic countries in 2022 raised concerns that monkeypox may want to unfold similarly afield, leading governments and public fitness enterprises to urgently increase vaccines and antiviral treatment options. And they're investing closely in products just like the JYNNEOS vaccine and the antiviral drug tecovirimat (TPOXX).
With the risk of monkeypox becoming a broader public health with growing danger, international locations are scrambling to secure powerful treatments and vaccines which has sparked an increased demand for the monkeypox vaccines. This increasing focus for prevention in opposition to rising infectious illnesses is using the marketplace for vaccines and treatments.
Limited Availability And High Production Costs Restrain the Monkeypox Vaccine And Treatment Market
A significant restraint in the monkeypox vaccine and treatment market is the limited availability and high production costs of vaccines and antiviral drugs. Both JYNNEOS and drugs such as tecovirimat (TPOXX), are complex and costly to manufacture, using specialised manufacturing processes, and thus face a limited global supply.
Expanding Market Potential In Endemic Regions To Create Opportunities For Monkeypox Vaccine And Treatment Market
Monkeypox vaccine and treatment market has a significant opportunity in terms of geographical expansion as there is lack of access to vaccines and monkey pox treatments in the endemic regions. The sustained health threat posed by monkeypox in these areas continues to drive demand for vaccines and treatments such as JYNNEOS and the smallpox medicine tecovirimat (TPOXX). The opportunity is because the developing countries not have the most robust healthcare infrastructure, making it necessary to develop sustainable solutions to prevent and manage the disease.
Monkeypox Vaccine and Treatment Market Segment Analysis
Based on product The segment consists of vaccines, antiviral drugs. In 2024, the monkeypox vaccine and treatment market was dominated by the drugs segment, capturing over 70.0% share. The rising patient pool of monkeypox disease, rising Distribution Channels of antiviral drugs, and high treatment cost due to symptomatic treatment of the disease are some pivotal factors driving the growth. In July 2022, SIGA's tecovirimat (oral) was approved by the U.K. for the treatment of monkeypox and other indications for children and adults with body weights above 13 kg. It is also approved in other European nations for treating monkeypox disease.
Based on Route of Administration the segment consists of oral, injectables, and other segments. The largest market share of more than 65.0% in the monkeypox vaccine and treatment market was held by oral route in 2024. As the oral route therapeutics exhibit higher demand compared to injected products as they are easy to administer, and oral products are also more economical. These factors are majorly attributed for the oral segment expansion. In addition, nearly all are orally administered drugs such as brincidofovir and cidofovir.
Based on Distribution Channel the segment consists of hospitals & Clinics, Government and public health distributors, retail pharmacies, online pharmacies, etc. Hospitals accounted for the largest revenue share of over 75.0% in 2024, and this segment is estimated to remain same throughout the forecast period (2025-2032). The increase in hospitalisations due to monkeypox outbreak and rising number of products used for symptomatic treatment in hospitals drive the growth of monkeypox vaccine and treatment. In addition to this, numerous steps taken by governmental authorities, including the American Hospital Association and the Department of Health and Human Services, ensure more effective treatment and ongoing monitoring of the health of patients suffering from monkeypox.
Monkeypox Vaccine and Treatment Market Regional Analysis
North America leads the Monkeypox Vaccine and Treatment Market
North America dominated the market with a revenue share of over 40.0% in 2024 due to the presence of a large number of leading players, coupled with various strategic initiatives undertaken by them. Moreover, the increase in disease prevalence and rising awareness among people regarding vaccination builds regional market expansion. In addition, favourable support from the government and higher R&D investments are anticipated provides lucrative growth opportunities for the North American region.
Monkeypox Vaccine and Treatment Market Competitive landscape
Emergent Biosolutions Leads the Monkeypox Vaccine And Treatment Market In 2024
Emergent BioSolutions continue to dominate the monkeypox vaccine and treatment arena in 2024, with research done on the ACAM2000 smallpox vaccine, which was designed to protect against smallpox, but also showed effectiveness against monkeypox. In response to recent outbreaks, the company has been working to boost production capacity to meet domestic and international demand. Emergent BioSolutions worked to build its antivirals pipeline, which now includes the monkeypox treatment TPOXX tecovirimat. In response to global fears about emerging infectious diseases, the company has also made strategic product access arrangements with governments and global health organisations. Consequently, Emergent BioSolutions is poised for a pivotal role in the reduction of the incrementally increasing worldwide demand for monkeypox vaccines and treatments by 2025.
Monkeypox vaccine and treatment market Scope table
|
|
Monkeypox Vaccine and Treatment Market Scope |
|||
|
|
Market Size in 2024 |
USD 103.5 Mn. |
||
|
|
Market Size in 2032 |
USD 225.12 Mn. |
||
|
|
CAGR (2025-2032) |
10.20% |
||
|
|
Historic Data |
2019-2024 |
||
|
|
Base Year |
2024 |
||
|
|
Forecast Period |
2025-2032 |
||
|
|
Segments Analysis |
By Product Vaccines Drugs Others |
||
|
|
By Route of Administration Oral Injectables Others |
|||
|
|
By Distribution Channels Hospitals and Clinics Government & Public Health Distributors Retail Pharmacies Online Pharmacies & Ecommerce Emergency Care Centres Others |
|||
|
Regional Scope |
North America: United States, Canada, Mexico Europe: United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, Rest of Europe Asia Pacific (APAC): China, Japan, South Korea, India, Australia, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Rest of APAC Middle East & Africa (MEA): South Africa, GCC, Nigeria, Egypt, Turkey, Rest of MEA South America: Brazil, Argentina, Colombia, Chile, Peru, Rest of South America |
|
||
Key Players in the monkeypox vaccine and treatment market
North America
- Bavarian Nordic (US)
- Johnson & Johnson (Janssen Pharmaceuticals) (US)
- SIGA Technologies (US)
- Emergent BioSolutions (US)
- Moderna (US)
- Vaxart (US)
- Sanofi Pasteur (US)
- Instituto Nacional de Salud Pública (INSP) (Mexico)
Europe
- AstraZeneca (UK)
- GSK (GlaxoSmithKline) (UK)
- ViiV Healthcare (UK)
- Valneva SE (France)
- Boehringer Ingelheim (Germany)
Asia Pacific
- Wuhan Institute of Biological Products (China)
- Shanghai Junshi Biosciences (China)
- Sihuan Pharmaceutical (China)
- Takeda Pharmaceuticals (Japan)
- Zydus Cadila (India)
Middle East and Africa
- ImmunoBiology (South Africa)
- Biovac (South Africa)
- Cairo Pharmaceutical Company (Egypt)
South America
- Bio-Manguinhos (Brazil)
- Laboratorio Sao Paulo (LSP) (Brazil)
- Instituto Butantan (Brazil)
- Laboratorio Elea Phoenix (Argentina)
Frequently Asked Questions
The expected CAGR of Monkeypox Vaccine and Treatment Market is 10.20%.
The segments of Monkeypox Vaccine and Treatment Market are by product, by Route of Administration, by distribution channels and by regions.
The Products of Monkeypox Vaccine and Treatment market are vaccines and drugs.
The major key players of Monkeypox Vaccine and Treatment market are Bavarian Nordic (US), Johnson & Johnson (Janssen Pharmaceuticals) (US), SIGA Technologies (US), Emergent BioSolutions (US), Moderna (US), etc.
1. Monkeypox Vaccine and Treatment Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Monkeypox Vaccine and Treatment Market: Competitive Landscape
2.1. SMR Competition Matrix
2.2. Key Players Benchmarking
2.2.1. Company Name
2.2.2. Service Segment
2.2.3. Distribution Channels Segment
2.2.4. Revenue (2024)
2.2.5. Geographical Presence
2.3. Market Structure
2.3.1. Market Leaders
2.3.2. Market Followers
2.3.3. Emerging Players
2.4. Mergers and Acquisitions Details
3. Monkeypox Vaccine and Treatment Market: Dynamics
3.1. Monkeypox Vaccine and Treatment Market Trends
3.2. Monkeypox Vaccine and Treatment Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Regulatory Landscape by Region
3.6. Key Opinion Leader Analysis for the Global Industry
3.7. Analysis of Government Schemes and Initiatives for Industry
4. Monkeypox Vaccine and Treatment Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
4.1. Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
4.1.1. Vaccines
4.1.2. Drugs
4.1.3. Others
4.2. Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
4.2.1. Oral
4.2.2. Injectables
4.2.3. Others
4.3. Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channels (2024-2032)
4.3.1. Hospitals and Clinics
4.3.2. Government & Public Health Distributors
4.3.3. Retail Pharmacies
4.3.4. Online Pharmacies & Ecommerce
4.3.5. Emergency Care Centres
4.3.6. Others
4.4. Monkeypox Vaccine and Treatment Market Size and Forecast, By Region (2024-2032)
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. Middle East and Africa
4.4.5. South America
5. North America Monkeypox Vaccine and Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
5.1. North America Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
5.1.1. Vaccines
5.1.2. Drugs
5.1.3. Others
5.2. North America Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
5.2.1. Oral
5.2.2. Injectables
5.2.3. Others
5.3. North America Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channels (2024-2032)
5.3.1. Hospitals and Clinics
5.3.2. Government & Public Health Distributors
5.3.3. Retail Pharmacies
5.3.4. Online Pharmacies & Ecommerce
5.3.5. Emergency Care Centres
5.3.6. Others
5.4. North America Monkeypox Vaccine and Treatment Market Size and Forecast, by Country (2024-2032)
5.4.1. United States
5.4.1.1. United States Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
5.4.1.1.1. Vaccines
5.4.1.1.2. Drugs
5.4.1.1.3. Others
5.4.1.2. United States Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
5.4.1.2.1. Oral
5.4.1.2.2. Injectables
5.4.1.2.3. Others
5.4.1.3. United States Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
5.4.1.3.1. Hospitals and Clinics
5.4.1.3.2. Government & Public Health Distributors
5.4.1.3.3. Retail Pharmacies
5.4.1.3.4. Online Pharmacies & Ecommerce
5.4.1.3.5. Emergency Care Centres
5.4.1.3.6. Others
5.4.2. Canada
5.4.2.1. Canada Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
5.4.2.1.1. Vaccines
5.4.2.1.2. Drugs
5.4.2.1.3. Others
5.4.2.2. Canada Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
5.4.2.2.1. Oral
5.4.2.2.2. Injectables
5.4.2.2.3. Others
5.4.2.3. Canada Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
5.4.2.3.1. Hospitals and Clinics
5.4.2.3.2. Government & Public Health Distributors
5.4.2.3.3. Retail Pharmacies
5.4.2.3.4. Online Pharmacies & Ecommerce
5.4.2.3.5. Emergency Care Centres
5.4.2.3.6. Others
5.4.3. Mexico
5.4.3.1. Mexico Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
5.4.3.1.1. Vaccines
5.4.3.1.2. Drugs
5.4.3.1.3. Others Open
5.4.3.2. Mexico Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
5.4.3.2.1. Oral
5.4.3.2.2. Injectables
5.4.3.2.3. Others
5.4.3.3. Mexico Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
5.4.3.3.1. Hospitals and Clinics
5.4.3.3.2. Government & Public Health Distributors
5.4.3.3.3. Retail Pharmacies
5.4.3.3.4. Online Pharmacies & Ecommerce
5.4.3.3.5. Emergency Care Centres
5.4.3.3.6. Others
6. Europe Monkeypox Vaccine and Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
6.1. Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.2. Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.3. Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4. Europe Monkeypox Vaccine and Treatment Market Size and Forecast, by Country (2024-2032)
6.4.1. United Kingdom
6.4.1.1. United Kingdom Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.1.2. United Kingdom Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.1.3. United Kingdom Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.2. France
6.4.2.1. France Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.2.2. France Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.2.3. France Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.3. Germany
6.4.3.1. Germany Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.3.2. Germany Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.3.3. Germany Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.4. Italy
6.4.4.1. Italy Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.4.2. Italy Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.4.3. Italy Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.5. Spain
6.4.5.1. Spain Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.5.2. Spain Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.5.3. Spain Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.6. Sweden
6.4.6.1. Sweden Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.6.2. Sweden Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.6.3. Sweden Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.7. Russia
6.4.7.1. Russia Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.7.2. Russia Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.7.3. Russia Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
6.4.8.2. Rest of Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
6.4.8.3. Rest of Europe Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7. Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
7.1. Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.2. Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.3. Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4. Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, by Country (2024-2032)
7.4.1. China
7.4.1.1. China Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.1.2. China Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.1.3. China Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.2. S Korea
7.4.2.1. S Korea Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.2.2. S Korea Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.2.3. S Korea Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.3. Japan
7.4.3.1. Japan Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.3.2. Japan Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.3.3. Japan Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.4. India
7.4.4.1. India Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.4.2. India Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.4.3. India Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.5. Australia
7.4.5.1. Australia Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.5.2. Australia Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.5.3. Australia Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.6. Indonesia
7.4.6.1. Indonesia Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.6.2. Indonesia Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.6.3. Indonesia Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.7. Malaysia
7.4.7.1. Malaysia Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.7.2. Malaysia Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.7.3. Malaysia Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.8. Philippines
7.4.8.1. Philippines Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.8.2. Philippines Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.8.3. Philippines Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.9. Thailand
7.4.9.1. Thailand Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.9.2. Thailand Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.9.3. Thailand Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.10. Vietnam
7.4.10.1. Vietnam Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.10.2. Vietnam Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.10.3. Vietnam Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
7.4.11. Rest of Asia Pacific
7.4.11.1. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
7.4.11.2. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
7.4.11.3. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8. Middle East and Africa Monkeypox Vaccine and Treatment Market Size and Forecast (by Value in USD Million) (2024-2032)
8.1. Middle East and Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.2. Middle East and Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.3. Middle East and Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8.4. Middle East and Africa Monkeypox Vaccine and Treatment Market Size and Forecast, by Country (2024-2032)
8.4.1. South Africa
8.4.1.1. South Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.4.1.2. South Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.4.1.3. South Africa Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8.4.2. GCC
8.4.2.1. GCC Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.4.2.2. GCC Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.4.2.3. GCC Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8.4.3. Egypt
8.4.3.1. Egypt Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.4.3.2. Egypt Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.4.3.3. Egypt Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8.4.4. Nigeria
8.4.4.1. Nigeria Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.4.4.2. Nigeria Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.4.4.3. Nigeria Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
8.4.5. Rest of ME&A
8.4.5.1. Rest of ME&A Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
8.4.5.2. Rest of ME&A Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
8.4.5.3. Rest of ME&A Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9. South America Monkeypox Vaccine and Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032
9.1. South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.2. South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.3. South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9.4. South America Monkeypox Vaccine and Treatment Market Size and Forecast, by Country (2024-2032)
9.4.1. Brazil
9.4.1.1. Brazil Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.4.1.2. Brazil Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.4.1.3. Brazil Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9.4.2. Argentina
9.4.2.1. Argentina Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.4.2.2. Argentina Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.4.2.3. Argentina Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9.4.3. Colombia
9.4.3.1. Colombia Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.4.3.2. Colombia Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.4.3.3. Colombia Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9.4.4. Chile
9.4.4.1. Chile Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.4.4.2. Chile Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.4.4.3. Chile Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
9.4.5. Rest Of South America
9.4.5.1. Rest Of South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Product (2024-2032)
9.4.5.2. Rest Of South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Route of Administration (2024-2032)
9.4.5.3. Rest Of South America Monkeypox Vaccine and Treatment Market Size and Forecast, By Distribution Channel (2024-2032)
10. Company Profile: Key Players
10.1. Bavarian Nordic
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Recent Developments
10.2. Johnson & Johnson (Janssen Pharmaceuticals)
10.3. SIGA Technologies
10.4. Emergent BioSolutions
10.5. Moderna
10.6. Vaxart
10.7. Sanofi Pasteur
10.8. Instituto Nacional de Salud Pública (INSP)
10.9. AstraZeneca
10.10. GSK (GlaxoSmithKline)
10.11. ViiV Healthcare
10.12. Valneva SE
10.13. Boehringer Ingelheim
10.14. Wuhan Institute of Biological Products
10.15. Shanghai Junshi Biosciences
10.16. Sihuan Pharmaceutical
10.17. Takeda Pharmaceuticals
10.18. Zydus Cadila
10.19. ImmunoBiology
10.20. Biovac
10.21. Cairo Pharmaceutical Company
10.22. Bio-Manguinhos
10.23. Laboratorio Sao Paulo
10.24. Instituto Butantan
10.25. Laboratorio Elea Phoenix
11. Key Findings
12. Industry Recommendations
13. Monkeypox Vaccine and Treatment Market: Research Methodology
